Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZAI LAB

17.320
+0.0600.35%
Volume:3.10M
Turnover:53.30M
Market Cap:19.36B
PE:-8.58
High:17.350
Open:16.910
Low:16.910
Close:17.260
52wk High:35.500
52wk Low:16.810
Shares:1.12B
HK Float Shares:1.12B
Volume Ratio:0.39
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-2.019
ROE:-28.97%
ROA:-13.29%
PB:3.28
PE(LYR):-8.58
PS:5.64

Loading ...

Stock Track | Zai Lab Plummets 5.04% Amid Broader Biomedical Sector Decline in Hong Kong

Stock Track
·
Oct 13

HK Movers | Biomedical Stocks Decline With Junshi Biosciences Down 8%

Tiger Newspress
·
Oct 13

Biotech Stocks Jump. Immunotech up 17%; Carsgen up 14%; BRII up 6%; JW Therap up 4%; Sirnaomics up 3%

Tiger Newspress
·
Oct 06

Zai Lab CFO Yajing Chen Reports Disposal of Common Shares

Reuters
·
Oct 04

Zai Lab Ltd (09688) Grants Stock Options and Restricted Stock Units

Stock News
·
Oct 02

Zai Lab Announces New Equity Incentive Plan Granting Share Options and Restricted Share Units to Employees

Reuters
·
Oct 02

HK Movers|Biotech Stocks Rose. Laekna Up 14%; RemeGen Rose 3%; Microport Up 2%; JW Therap, Zai Lab And Lepu Up 1%

Tiger Newspress
·
Sep 29

Shenwan Hongyuan Initiates Coverage on ZAI LAB (09688) with "Buy" Rating, Sets Target Price at HK$35.2

Stock News
·
Sep 24

Biotech Stocks Rebound. Transthera up 16%; Hightide up 13%; Clover Bio up over 9%; Alphamab up 8%; Zai Lab, Jacobio up over 6%; Mirxes up 5%

Tiger Newspress
·
Sep 12

Stock Track | Zai Lab Soars 6.60% in Pre-market Following 12% Surge Amid Renewed Interest in Chinese Stocks

Stock Track
·
Sep 12

US Stock Movement: Popular Chinese Concept Stocks Surge, Zai Lab Ltd (ZLAB.US) Up Over 12%

Stock News
·
Sep 11

ZAI LAB (09688) Grants Stock Options and Restricted Share Units

Stock News
·
Sep 09

Zai Lab Ltd. Announces New Share Options and Restricted Share Units Under 2024 Equity Incentive Plan

Reuters
·
Sep 09

Hong Kong Stock Movement | Zai Lab (09688) Rises Over 5% as FORTITUDE-102 Study Data Expected in 2H25 or 1H26

Stock News
·
Sep 08

Zai Lab Ltd : Leerink Partners Cuts Target Price to $74 From $75

THOMSON REUTERS
·
Sep 04

Zai Lab Says Bemarituzumab Not as Beneficial as Previously Thought in Gastric Cancer; Shares Fall 13%

MT Newswires Live
·
Sep 04

HK Movers|Pharma Stocks Fell. Zai Lab Plummeted 11%; JW Therap Down 7%; Hengrui Pharma Down 5%; WuXi AppTec Down 4%

Tiger Newspress
·
Sep 04

Stock Track | ZAI LAB Plummets 7.03% as Bemarituzumab Shows Diminished Survival Benefit in Gastric Cancer Trial

Stock Track
·
Sep 04

ZAI LAB (09688): Latest Update on Amgen's Bemarituzumab FORTITUDE-101 Phase III Clinical Trial

Stock News
·
Sep 03

Zai Lab Ltd. Awaits Results from FORTITUDE-102 Trial for Bemarituzumab in Gastric Cancer Treatment Following Attenuated Survival Benefit in Phase 3 FORTITUDE-101 Study

Reuters
·
Sep 03